In an experimental model of DSS- or pathogenic bacteria-induced colitis, RA was shown to attenuate inflammation by increasing IL-22 production by ILC3 and Tγδ cells and, consequently, increasing the synthesis of antimicrobial peptides [75] or by decreasing TNF levels and NFκB activation [115]. The gene discussed is TNF; the disease is colitis.